Retests –Dr Reddys, Sun Pharma. Risk-Reward–Petronet, TCS. False–Airtel. Breakout–OFSS.

Looking at a few stock which after breakout are doing a retest. A retest buying is tough in terms of timing as there is a range to buy and the stock can stay in this range for quite some time before the next move. A stoploss would be at the breakout candle lows or the last swing lows.

A lot of people who prefer breakouts tend to find participating in such a trade difficult ( like me). But tracking a retest gives you more conviction even if you participate in the next breakout.

Dr Reddys – Big Volume uptick took it past the 4200 resistance into All time Highs. Now a retest at 4200-4450 a zone to look for entry with stops at 4100.

Dr Reddys

Sun Pharma – Back to testing the breakout. Can pre-empt or look for a break beyond 550-555.

Sun Pharma

Now a few risk-reward setups in which one is trying to pre-empt the next move.

TCS – Multiple attempts at 2300. Last attempt a failure. Now making a base at 2230 odd levels. Time to pre-empt with a stoploss below 2150 or wait for a break above 2320-2350.

TCS pre

Petronet LNG – Not much of a reason but purely a risk-reward bet with stops at 240-242 .. Or wait for a clear move beyond 265.

Petronet Lng

Bharti Airtel – A false breakdown in making ?. Watch for 540-545 to sustain.

Bharti Airtel

Oracle Financial Services – A clean pattern. Now to wait for a clean confirmation through price.


Brief Video on Product Offering – Online Video Course and Analyse with Me -

After receiving a lot of inquiries,Have created a small video explaining the course offerings

Online Technical Analysis Video Course

Analyse With Me – A Practical Approach to Technical Analysis

Advisory Services

Technical Traders Club

QuickGains F&O -






  • DISCLOSURE Nooresh Merani

    Securities covered above:  All listed on the blog –

    SEBI Registration disclosure - Investment Adviser

    Financial Interest:

    Nooresh Merani and his family/associates/ analysts would have exposure in the securities mentioned in the above report/article.

    Nooresh Merani and his family/associates/ analysts do not have any financial interest/beneficial ownership of more than 1% in the company covered by Analyst.

    Nooresh Merani and his family/associates/ analysts have not received any compensation from the company/third party covered in the above report/article ever.

    Nooresh Merani and his family/associates/ analysts  has not served as an officer, director or employee of company covered in the report/article and has not been engaged in market-making activity of the company covered in the report/article.

    The views expressed are based solely on information available publicly and believed to be true. Investors are advised to independently evaluate the market conditions/risks involved before making any investment decision

    Also read the detailed disclaimer -

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.